April 2014
Volume 55, Issue 13
Free
ARVO Annual Meeting Abstract  |   April 2014
Long term outcomes of Ex-PRESS glaucoma filtration surgery in African American patients with glaucoma
Author Affiliations & Notes
  • Ann Mary John
    Ophthalmology, Rutgers New Jersey Medical School, Newark, NJ
  • Tamara L Berezina
    Ophthalmology, Rutgers New Jersey Medical School, Newark, NJ
  • Robert D Fechtner
    Ophthalmology, Rutgers New Jersey Medical School, Newark, NJ
  • Albert S Khouri
    Ophthalmology, Rutgers New Jersey Medical School, Newark, NJ
  • Footnotes
    Commercial Relationships Ann John, None; Tamara Berezina, None; Robert Fechtner, Alcon (C), Alcon (R); Albert Khouri, Alcon (R)
  • Footnotes
    Support None
Investigative Ophthalmology & Visual Science April 2014, Vol.55, 3170. doi:
  • Views
  • Share
  • Tools
    • Alerts
      ×
      This feature is available to authenticated users only.
      Sign In or Create an Account ×
    • Get Citation

      Ann Mary John, Tamara L Berezina, Robert D Fechtner, Albert S Khouri; Long term outcomes of Ex-PRESS glaucoma filtration surgery in African American patients with glaucoma. Invest. Ophthalmol. Vis. Sci. 2014;55(13):3170.

      Download citation file:


      © ARVO (1962-2015); The Authors (2016-present)

      ×
  • Supplements
Abstract
 
Purpose
 

To compare intraocular pressure (IOP) reduction, use of glaucoma medications, numbers of post-operative interventions, and success rates in African American patients undergoing Ex-PRESS glaucoma filtration surgery or trabeculectomy for treatment of glaucoma.

 
Methods
 

A retrospective chart review was performed on 56 African American patients undergoing Ex-PRESS glaucoma shunt (EXP) or trabeculectomy (Trab) between 8/3/2004 and 10/18/2012. All procedures were augmented with Mitomycin C. Data collected included IOP and glaucoma medication use at baseline and post-operative week 1, Month (M) 1, M3, M6, M12, M18, and M24. Post-operative interventions including laser suture lysis (LSL) and 5FU injections were analyzed. Proportion of eyes achieving >30% IOP reduction from baseline, and eyes failing and requiring more surgery were determined. Means, SD, Chi square, and Student T Test were performed.

 
Results
 

56 subjects (EXP 28, Trab 28) were included in the analysis. There was a statistically significant reduction (p<0.05) in IOP and number of glaucoma medications at all time points compared to baseline for both groups. Extent of IOP reduction between groups was not statistically significant at any time point, except post-operative week 1 (Table 1). Mean number of glaucoma medications between groups was not significant, except at 3 months and 2 years (lower in EXP group, Table 1). The cumulative number of post-operative interventions within 3 months (LSL and 5FU) was significantly greater for TRAB than EXP (3.89±2.4 vs. 2.36±2.2, p= 0.007). Proportions of eyes achieving>30% IOP reduction from baseline were comparable between both groups (Table 2). Two eyes failed in each the EXP and TRAB groups.

 
Conclusions
 

In our cohort of African American patients, the Ex-PRESS shunt was as effective as trabeculectomy in reducing IOP and use of glaucoma medications up to two years. The Ex-PRESS group required fewer post-operative interventions than trabeculectomy patients within 3 months of surgery.

 
 
Table 1: IOP and number of medications
 
Table 1: IOP and number of medications
 
 
Table 2: Success rates
 
Table 2: Success rates
 
Keywords: 568 intraocular pressure • 765 wound healing  
×
×

This PDF is available to Subscribers Only

Sign in or purchase a subscription to access this content. ×

You must be signed into an individual account to use this feature.

×